The largest database of trusted experimental protocols

Dako autostainer autostainer plus

Manufactured by Agilent Technologies
Sourced in Italy

The Dako Autostainer/Autostainer Plus is a fully automated immunohistochemistry (IHC) and in situ hybridization (ISH) staining instrument. It is designed to perform standardized and reproducible staining of tissue sections on glass slides.

Automatically generated - may contain errors

3 protocols using dako autostainer autostainer plus

1

Quantifying Myocardial Infarct Size

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heart tissue was fixed in 10% buffered formalin, embedded in paraffin, and cut into 5-µm-thick sections. The sections were stained with Masson’s trichrome to determine the percentage of the infarct size, and the morphology of the infarcted size was identified using ImageJ software (ver. 1.47v; U.S. National Institutes of Health, Bethesda, MD). The percentage of the infarct size was assessed as the total infarct circumference divided by the total LV circumference × 100, as described [16 ]. Immunohistochemistry staining was performed by the immune-peroxidase method using paraffin-embedded tissue sections. After inhibition of endogenous peroxidase activity, the sections were incubated with primary rat anti-mouse Mac-3 antibody (#550292, BD Bioscience, Franklin Lakes, NJ), or rabbit anti-human CD3 antibody (#20006172F, Dako Autostainer/Autostainer Plus, Dako, Glostrup, Denmark) and then incubated at 4°C overnight with the respective secondary antibodies. Following visualization with 3,3′-diaminobenzidine (#10107863, Sigma–Aldrich, St. Louis, MO) according to the manufacturer’s instructions, the sections were finally counterstained with Mayer’s hematoxylin (Wako, Tokyo). All images were digitized using a microscope (Olympus AX80; Olympus Optical, Tokyo) equipped with a high-resolution camera (Nikon D2X; Nikon, Tokyo).
+ Open protocol
+ Expand
2

Immunohistochemistry Protocol for Breast Cancer Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The immunohistochemistry technique was performed using the EnVision FLEX Mini Kit, High pH high‐sensitivity visualisation system (Dako Autostainer/Autostainer Plus, Dako). The PT Link (Dako) module was used to pretreat the samples at a maximum temperature of 95°C with the corresponding retrieval solution according to the antibody used.
The sections were incubated with the primary antibodies:

IO Path Mouse Anti‐Human Progesterone Receptor Monoclonal Antibody. Clone PR10A9. Prediluted (Beckman Coulter).

Mouse Anti‐Human Oestrogen Receptor α Monoclonal Antibody. Clone 1D5. Dilution 1:35 (Dako).

Rabbit Anti‐Human HER2 Polyclonal Antibody. Dilution 1:250 (Dako).

Mouse Anti‐Human COX‐2 Monoclonal Antibody. Clone CX‐294. Dilution 1:100 (Dako).

The negative control was performed with a mouse negative control (FLEX Negative Control, Mouse; Dako) and a rabbit negative control (FLEX Negative Control, Rabbit; Dako). According to the manufacturer (Dako), as positive controls, endometrium was used for the anti‐PR and anti‐ER antibodies and the adrenal gland was used as the control organ for the anti‐COX‐2 antibody. Normal mammary glandular tissue can present low expression of HER2 antibody staining. Following American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) recommendations for humans, HER2 positivity (overexpression) was considered only for 3+ tumours.
+ Open protocol
+ Expand
3

Immunostaining of CD1a-Positive Structures

Check if the same lab product or an alternative is used in the 5 most similar protocols
After de-paraffinization, 5 μm thick sections were immunostained to visualize CD1a-positive structures using Dako Autostainer/Autostainer Plus (Dako, Milan, Italy) and CD1a antibodies (M3571 anti-human CD1a Dako) diluted 1:100 in EnVision buffer. Each section was incubated with peroxidase-blocking serum (EnVision FLEX Peroxidase-Blocking Reagent, Dako) for 5 minutes to quench non-specific binding and then for 30 minutes with the primary antibody. After this, sections were incubated with a labeled polymer (EnVision FLEX /HRP, Dako) for 20 minutes and 3,3’-diaminobenzidine (EnVision FLEX Substrate buffer, + DAB + Chromogen; Dako) to label positive primary antibody binding. All the sections were finally counterstained with Hematoxylin (EnVision FLEX Hematoxylin, Dako) for 5 minutes to reveal the presence of nuclei, then dehydrated with an increasing scale of alcohol solutions (70%, 95%, 99%), cleared with xylene and mounted. These steps were performed at room temperature.[16] (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!